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Recent evidence indicates that high-sensitivity C-reactive protein (hs-CRP), an acute phase of an inﬂammatory marker, might be
associated with atherosclerosis, hypertension, and other cardiovascular diseases. The present study was performed to assess the
possible link between plasma hs-CRP and membrane ﬂuidity (a reciprocal value of membrane microviscosity) in hypertensive
elderly men. We measured the membrane ﬂuidity of red blood cells (RBCs) in hypertensive and normotensive elderly men using
an electron spin resonance and spin-labeling method. Membrane ﬂuidity of RBCs was decreased in hypertensive elderly men
compared with normotensive elderly men. Plasma hs-CRP levels were signiﬁcantly higher in hypertensive elderly men than in
normotensive elderly men. In contrast, plasma nitric-oxide- (NO-) metabolite levels were lower in hypertensive elderly men than
innormotensiveelderly men.The reduced membraneﬂuidity ofRBCswasassociatedwithincreasedplasmahs-CRPanddecreased
plasmaNO-metabolite levels. Ina multivariateregression analysis,plasmahs-CRP wasanindependent determinant ofmembrane
ﬂuidity of RBCs after adjustment for general risk factors. The results suggest that CRP might have a close correlation with the
rheologic behavior of RBCs and the microcirculation and would contribute, at least in part, to the circulatory dysfunction and
vascular complications in hypertensive elderly men.
1.Introduction
Evidence indicates that inﬂammation may actively partici-
pate in the development and progression of atherosclerosis
and cardiovascular disease processes [1]. It is well recognized
that high-sensitivity C-reactive protein (hs-CRP), an acute-
phase of inﬂammatory marker, might be associated with
increased risk of cardiovascular events [2, 3]. Recently, it has
been shown that CRP could reduce the nitric oxide (NO)
bioavailability by itself, which would induce endothelial and
cardiovascular dysfunctions. Venugopal et al. demonstrated
that CRP directly decreased endothelium type of NO syn-
thase (eNOS) expression in human aortic endothelial cells
in vitro [4]. Qamirani et al. showed that CRP inhibited en-
dothelium-dependent NO-mediated dilatation of porcine
coronary arterioles [5].In a clinicalstudy,it was also demon-
strated that increased levels of hs-CRP were associated with
reduced endothelium-mediated dilatory responses of the
arteries [6]. However, the precise role of inﬂammation in the
circulatory dysfunction in hypertension remains unclear.
Ithas beenproposed thatabnormalitiesin physicalprop-
erties ofthecell membranesmay underlie thedefectsthatare
strongly linked to hypertension, stroke, and other cardiovas-
cular disease conditions [7–9]. An electron spin resonance
(ESR) and spin-labeling method has been developed to eval-
uate the membrane ﬂuidity (a reciprocal value of membrane
microviscosity) andperturbations ofthemembranefunction
by external agents [8, 9] .T h em e m b r a n eﬂ u i d i t yi sap h y s i c -
ochemical feature of biomembranes and is an important
factor in modulating the cell rheologic behavior [8, 9]. Using2 International Journal of Hypertension
Table 1: Clinical characteristics and laboratory ﬁndings of hypertensive (HT) and normotensive (NT) men.
NT HT
Number of subjects 18 29
Age (y.o.) 64 ± 26 3 ± 2
Body mass index (kg/m2) 24.2 ± 0.7 24.1 ± 0.5
Systolic blood pressure (mmHg) 124 ± 2 147 ± 1∗
Diastolic blood pressure (mmHg) 69 ± 28 7 ± 1∗
Heart rate (beats/min) 75 ± 27 2 ± 2
Erythrocyte counts (104 cells/μL) 458 ± 11 474 ± 8
Hemoglobin (g/dL) 14.2 ± 0.4 14.1 ± 0.2
Hematocrit (%) 43.2 ± 1.0 42.9 ± 0.6
Leucocyte counts (103 cells/μL) 5.5 ± 0.3 5.4 ± 0.2
Platelets (104 cells/μL) 21 ± 12 3 ± 1
Total cholesterol (mg/dL) 211 ± 6 209 ± 7
High-density lipoprotein cholesterol (mg/dL) 51 ± 25 2 ± 3
Low-density lipoprotein cholesterol (mg/dL) 134 ± 6 127 ± 7
Triglycerides (mg/dL) 120 ± 11 131 ± 12
Serum sodium (mmol/L) 140.8 ± 0.1 140.1 ± 0.2
Serum potassium (mmol/L) 4.0 ± 0.1 4.0 ± 0.1
Serum creatinine (mg/dL) 0.8 ± 0.1 0.9 ± 0.1
Fasting plasma glucose (mg/dL) 109 ± 3 116 ± 8
Values are mean ± SEM. ∗P<0.05 between HT and NT.
the ESR method, we have been performing a series of exper-
iments regarding the membrane ﬂuidity of red blood cells
(RBCs) in hypertension and have shown that membrane
ﬂuidity was signiﬁcantly lower in hypertensive subjects than
in normotensive subjects, particularly in the elderly [10–
15]. Because the deformability of RBCs might be highly
dependent on the membrane ﬂuidity [8, 9], the reduction
in membrane ﬂuidity could cause a disturbance in the blood
rheologic behavior and the microcirculation, which might
contributeto the pathophysiology of hypertension and other
circulatory disorders. In the present study, in order to assess
the role of inﬂammation in the regulation of membrane
function in hypertension in the elderly, we investigated
the relationships between plasma hs-CRP and membrane
ﬂuidity of RBCs in hypertensive and normotensive elderly
men using the ESR and the spin-labeling method.
2.Subjectsand Methods
2.1. Subjects. A total of 29 men with untreated essential hy-
pertension(age63 ±2 yearsold)were studied andcompared
with 18 age-matched normotensive men (age 64 ± 2y e a r s
old) (Table 1). The characteristics and laboratory ﬁndings
in both groups were shown in Table 1.A l ls u b j e c t sh a dn o
history of haematologic or hepatic disorders. All men were
nonsmokers. They had similar life styles and dietary habits
and were instructed to avoid any changes in dietary habits
at least 12 weeks before the study. The study was approved
by a local research committee of Kansai University of Health
Sciences. Written informed consent was obtained from all
participants when they were informed about the nature and
objective of the study.
2.2. Electron Spin Resonance (ESR) Measurements of RBCs.
Blood sampling was performed by venipuncture after 30
minutes of bed rest while fasting. The procedures of RBC
preparation and ESR measurements were shown previously
[9–15]. We evaluated the values of outer and inner hyperﬁne
splitting (2T   and 2T ⊥ in tesla (T), resp.) in the ESR spec-
trum for the spin label agents (5-nitroxide stearate, Aldrich
Co., Ltd., Milwaukee, WI, USA) (Figure 1), and calculated
the order parameter (S) [10–16]. The greater the value of the
order parameter (S) was, the lower the membrane ﬂuidity of
RBCs was.
2.3. Nitric Oxide (NO) Metabolites (Nitrite and Nitrate) Anal-
ysis. The plasma levels of NO metabolites (nitrite and ni-
trate) were measured according to themethod described pre-
viously [17].
2.4.Statistical Analysis. Valuesareexpressedasmean ±SEM.
Thediﬀerencesbetweenhypertensiveandnormotensivemen
were analyzed using an unpaired Student’s t-test. Linear re-
gression analysis was performed to assess the relationships
between membrane ﬂuidity (order parameter: S) of RBCs
and plasma hs-CRP or NOmetabolite levels.Multivariate re-
gression analysis with membrane ﬂuidity (order parameter:
S) of RBCs as a dependent variable and plasma hs-CRP, age,
body mass index (BMI), hypercholesterolemia (more thanInternational Journal of Hypertension 3
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Figure 1: Representative electron spin resonance (ESR) spectrum
of red blood cells (RBCs) for the fatty acid spin-label agents (5-
nitroxide stearate). We calculated the order parameter (S) from
outer and inner hyperﬁne splitting (2T   and 2T ⊥[10–16]). The
greater the value of the order parameter (S) was, the lower the
membraneﬂuidity ofRBCs was [10–16]. (S:order parameter, 2T  :
outer hyperﬁne splitting, 2T ⊥:i n n e rh y p e r ﬁ n es p l i t t i n g ,T :t e s l a . )
220mg/dL), hyperglycemia (more than110mg/dL),and sys-
tolic blood pressure as independent variables was also per-
formed. A P value less than 0.05 was accepted as the level of
signiﬁcance.
3.Results
3.1. Membrane Fluidity of RBCs in Hypertensive and Nor-
motensive Elderly Men. T h eo r d e rp a r a m e t e r( S )f o r5 - n i -
troxide stearate in the ESR spectra of RBCs was signiﬁcantly
higher in hypertensive elderly men (HT) than in normoten-
sive elderly men (NT) (HT 0.729 ± 0.002, mean ± SEM,
n = 29, NT 0.718 ± 0.002, n = 18, P<0.01). The ﬁnding
indicated that membrane ﬂuidity of RBCs was signiﬁcantly
l o w e ri nh y p e r t e n s i v ee l d e r l ym e nt h a ni nn o r m o t e n s i v e
elderly men.
3.2. Plasma High-Sensitivity C-Reactive Protein and Plasma
Nitric-Oxide-Metabolite Levels in Hypertensive and Normot-
ensive Elderly Men. The plasma hs-CRP levels were signiﬁ-
cantly higher in hypertensive elderly men than in normoten-
sive elderly men (HT: 0.157 ± 0.022mg/dL, n = 29, NT:
0.072 ± 0.009mg/dL, n = 18, P<0.01). In contrast,
the plasma NO metabolites were lower in hypertensive
elderly men than in normotensive elderly men (HT: 36.0 ±
2.4μmol/L, n = 29, NT: 52.5 ± 5.2μmol/L, n = 18, P<
0.0 1 ) .I na d d i t i o n ,i nt h eo v e r a l la n a l y s i so fh y p e r t e n s i v e
and normotensive elderly men, plasma hs-CRP levels were
inversely correlated with plasma NO metabolites (r =
−0.291, n = 47, P<0.05) (Figure 2).
3.3. Relationship between Membrane Fluidity of Red Blood
Cells and Plasma High-Sensitivity C-Reactive Protein, or
Plasma Nitric-Oxide-Metabolite Levels in Hypertensive and
Normotensive Elderly Men. The order parameter (S) of
RBCs was signiﬁcantly correlated with plasma hs-CRP levels
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Figure 2: Inverse correlation between plasma high-sensitivity C-
reactive protein (hs-CRP) and plasma nitric-oxide- (NO-) metabo-
lite levels in hypertensive and normotensive elderly men.
(r = 0.416, n = 47, P<0.01) (Figure 3)a n dw a si n v e r s e l y
correlated with plasma NO metabolite levels (r =− 0.362,
n = 47, P<0.05).
In a multivariate regression analysis after adjustment for
general risk factors, plasma hs-CRP was an independent
determinant of membrane ﬂuidity (order parameter: S) of
RBCs (Table 2).
4.Discussion
Evidence indicates that hs-CRP, an acute-phase of inﬂam-
matory marker, might be associated with increased risk of
cardiovascular events[2, 3]. In the present study, we assessed
the relationships between plasma hs-CRP levels and the
membrane ﬂuidity (a reciprocal value of membrane micro-
viscosity) of RBCs in hypertensive and normotensive elderly
men using the ESR and the spin-labeling method. The
present study showed that the membrane ﬂuidity of RBCs
was decreased in hypertensive elderly men compared with
normotensive elderly men. The result might be consistent
with our previous ﬁndings showing that the cell membranes
were stiﬀer and less ﬂuid in hypertensive subjects [10–15].
Plasma hs-CRP levels were signiﬁcantly higher in hyperten-
sive elderly men than in normotensive elderly men and cor-
related with the order parameter (S) of RBCs, indicating that
the reduced membrane ﬂuidity of RBCs might be associated
with elevated inﬂammatory status. To our knowledge, this is
the ﬁrst report demonstrating that CRP might have a close
correlation with membrane ﬂuidity of RBCs in humans.4 International Journal of Hypertension
0.705
0.715
0.725
0.735
0.745
0.75
0
0
0.1 0.2 0.3 0.4 0.5 0.6
O
r
d
e
r
 
p
a
r
a
m
e
t
e
r
 
(
S
)
Plasma hs-CRP (mg/dL)
n = 47
HT, n = 29
r = 0.416
NT, n = 18
0.74
0.73
0.72
0.71
P<0.01
Figure 3: Correlation between plasma high-sensitivity C-reactive
protein (hs-CRP) and membrane ﬂuidity (order parameter: S) of
red blood cells (RBCs) in hypertensive and normotensive elderly
men.
Table 2: Multivariate regression analysis for predicting order pa-
rameter (S) of RBCs.
SRC t-value P value
Age (y.o) −0.215 −1.288 0.2053
Body mass index (kg/m2) −0.197 −1.190 0.2409
Hypercholesterolemia (
￿220mg/dL) −0.269 −1.986 0.0539
Hyperglycemia (
￿110mg/dL) 0.178 1.318 0.1951
Systolic blood pressure (mmHg) 0.339 2.552 0.0146
Plasma hs-CRP (mg/dL) 0.353 2.603 0.0129
R2 = 0.373, n = 47, F = 3.972, P = 0.0033.
SRC: standard regression coeﬃcient.
Multivariate regression analysis also showed that plasma hs-
CRP was an independent determinant of membrane ﬂuidity
of RBCs after adjustment for general risk factors. Because
the deformability of RBCs might be highly dependent on
the membrane ﬂuidity [8, 9], the reduction in membrane
ﬂuidity associated with increased hs-CRP levels could cause
adisturbance in thebloodrheologic behaviorand themicro-
circulation.
It was shown that shear rate, shear stress, and blood vis-
cosity were correlated with membrane ﬂuidity of RBCs [18].
The ﬁnding proposed that in vivo shear forces might par-
ticipate in the control of RBC membrane ﬂuidity and that
RBCs might adapt their membrane properties to blood ﬂow
conditions. It was also demonstrated that RBC membranes
might become more rigid after myocardial infarction, which
could contribute to the decreased RBC deformability and
the increased blood viscosity in this group of patients [19].
On the other hand, Cazzola et al. [20] reported that the
membrane ﬂuidity of RBCs was decreased in the obese
subjects and proposed that a decrease in RBC membrane
ﬂuidity could contribute to a reduction of the rate of blood
ﬂow and the oxygen diﬀusion through the RBC membranes
and its exchange with tissues. It might be, therefore, possible
that alterations in RBC membrane ﬂuidity with elevated hs-
CRP levels would be strongly linked to the progression of
circulatory disorders.
Recently, it was demonstrated that CRP might directly
impair the NOS expression in human aortic endothelial cells
in vitro [4]. It was also shown that endothelium-dependent
vasodilatory responses or microvascular endothelial func-
tions were reduced in humans with elevated plasma hs-CRP
levels [6, 21]. The results of the present study demonstrated
that plasma hs-CRP levels were inversely correlated with
plasmaNOmetabolitesintheoverallanalysisofhypertensive
and normotensive elderly men. One hypothesis isthathigher
hs-CRPlevelscouldbeaccompaniedbythereducedNOpro-
duction and endothelial dysfunction. In a study presented
earlier, it was shown that an NO donor signiﬁcantly im-
proved membrane ﬂuidity of RBCs in hypertensive sub-
jects, indicating that NO could have a beneﬁcial eﬀect on
the rheologic behavior of RBCs and the microcirculation
in hypertension [13–15]. We also demonstrated that the
reduced membrane ﬂuidity of RBCs was associated with
the decreased plasma NO metabolites in overall analysis of
hypertensive and normotensive elderly men, which might be
consistent withourpreviousﬁndings [13,17].It is, therefore,
strongly suggested that the eﬀe c t so fC R Po nm e m b r a n e
ﬂuidity of RBCs might be mediated, at least in part, by the
impaired NO bioavailability, although direct actions of CRP
on membrane structural and functional properties cannot
be excluded. Further studies should be performed to assess
more precisely the relationships between CRP and NO and
their role in the regulation of membrane functions and
circulatory mechanisms in hypertension.
5.Conclusion
The results of the present study demonstrated that plasma
hs-CRP levels were elevated in hypertensive elderly men
compared with normotensive elderly men. In addition, it
was shown that the reduced membrane ﬂuidity of RBCs
was correlated with higher plasma hs-CRP and lower plasma
NO metabolite levels, indicating that abnormalities in RBC
membranes might be associated with increased inﬂamma-
tory status and endothelial dysfunction in hypertension.
Although this is a cross-sectional and correlative study in
Japanese men, the results of the present study suggest that
CRPmighthavea closecorrelationwiththerheologic behav-
ior of RBCs and the microcirculation and would contribute,
at least in part, to the circulatory dysfunctions and vascular
complications in hypertensive elderly men. Moreover, a
better knowledge of the inﬂammatory biomarker and cellu-
lar mechanisms underlying membrane abnormalities could
provide useful information concerning the pathogenesis,
treatment, and prognosis of hypertension in the elderly.International Journal of Hypertension 5
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